L2L L2L Microarray Analysis Tool

Results for N01A.profile.d50

Results summary View all lists in L2L MDB View all genes in N01A.profile.d50
List Name Description Total
uvc_xpcs_all_dn Down-regulated at any timepoint following treatment of XPB/CS fibroblasts with 3 J/m^2 UVC 1048 2.59 9 3.47 1.43e-03
erm_ko_testes_dn Down-regulated in testes from 4 week old ERM knockout mice, compared to wild-type controls 24 0.06 2 33.71 1.63e-03
uvc_xpcs_8hr_dn Down-regulated at 8 hours following treatment of XPB/CS fibroblasts with 3 J/m^2 UVC 911 2.25 8 3.55 2.24e-03
pubertal_mammary_4-5wks_up Up-regulated > 1.5-fold in the developing mouse mammary gland between 4 and 5 weeks of age. 368 0.91 5 5.50 2.41e-03
cmv_hcmv_timecourse_12hrs_dn Down-regulated in fibroblasts following infection with human cytomegalovirus (at least 3-fold, with Affymetrix change call, in at least two consectutive timepoints), with maximum change at 12 hours 33 0.08 2 24.52 3.07e-03
hsc_mature_adult Up-regulated in mouse mature bood cells from adult bone marrow, compared to hematopoietic progenitors (Cluster vii, Mature Blood Cells Shared + Adult) 427 1.06 5 4.74 4.52e-03
ras-grf1_ko_dn Down-regulated in LCM-dissected hippocampus samples of Ras-GRF1 knockout mice compared to wild-type controls. 41 0.10 2 19.73 4.70e-03
et743_sarcoma_dn Down-regulated following treatment with Et-743 at any timepoint in at least 8 of 11 sarcoma cell lines 459 1.13 5 4.41 6.09e-03
brca_prognosis_neg Genes whose expression is consistently negatively correlated with breast cancer outcomes - higher expression is associated with metastasis and poor prognosis 166 0.41 3 7.31 8.38e-03

Raw data (tab-delimited .txt)